Results 101 to 110 of about 33,252 (219)

Transnasal endoscopy for eosinophilic esophagitis surveillance in adolescents with mild autism spectrum disorder: A single‐center case series

open access: yesJPGN Reports, Volume 7, Issue 3, Page 465-470, August 2026.
Abstract Children with autism spectrum disorder (ASD) often experience sensory sensitivities and procedural anxiety, which can complicate sedated esophagogastroduodenoscopy (EGD). Transnasal endoscopy (TNE) is a less invasive, unsedated alternative, but data on its use in this population are limited.
Natalee Sarintra   +6 more
wiley   +1 more source

Malta Consensus Statements on Paranasal Sinus Disorders in SCUBA Diving: Results of a Delphi Study

open access: yesLaryngoscope Investigative Otolaryngology, Volume 11, Issue 4, August 2026.
ABSTRACT Objectives To establish expert consensus on the diagnostic approach, treatment strategies, and fitness‐to‐dive assessment for divers with paranasal sinus disease, addressing the current lack of specific guidelines for this frequent diving‐related disorder.
B. Y. Roukema   +4 more
wiley   +1 more source

Clinical Images: Features of IgG4‐related disease in a patient with granulomatosis with polyangiitis

open access: yes
ACR Open Rheumatology, Volume 8, Issue 8, August 2026.
Florian Kollert   +9 more
wiley   +1 more source

Patient Perspectives on Systemic Bevacizumab Treatment for Recurrent Respiratory Papillomatosis

open access: yesLaryngoscope Investigative Otolaryngology, Volume 11, Issue 4, August 2026.
In this cross‐institutional survey of 24 patients with recurrent respiratory papillomatosis who had undergone both systemic bevacizumab and surgical treatment, patients reported significantly better voice, breathing, swallowing, and mental well‐being with bevacizumab, along with less pain, fewer side effects, and fewer missed workdays.
Sarah Gao   +7 more
wiley   +1 more source

Striking Bone Marrow Plasmacytosis Resulting From Visceral Leishmaniasis

open access: yes
American Journal of Hematology, Volume 101, Issue 8, Page 2007-2008, August 2026.
Vishakha Sovani   +2 more
wiley   +1 more source

A Low‐Cost, Easily Implementable Model for Multiskill Hands‐On Training in Otolaryngology Education

open access: yesLaryngoscope Investigative Otolaryngology, Volume 11, Issue 4, August 2026.
We developed and evaluated a short‐duration, low‐cost, multistation hands‐on training model in otolaryngology for medical students and junior residents. The program significantly improved self‐assessed knowledge, procedural skills, and interest in otolaryngology, supporting its feasibility and educational value as a reproducible model for early ...
Takahiro Inoue   +8 more
wiley   +1 more source

Integrated Clinical Trial and Molecular Profiling Reveals Immune Drivers of Chronic Hand Eczema

open access: yesAllergy, Volume 81, Issue 8, Page 2815-2832, August 2026.
This study performed an unbiased molecular profiling of CHE patients across diverse etiologies to identify shared pathogenic drivers and evaluate the impact of IL‐4Rα blockade via dupilumab over 16 weeks. CHE shows a mixed immune signature involving type 1, 2, and 3 pathways with features of atopic dermatitis and psoriasis.
Perrine Gery   +25 more
wiley   +1 more source

Epistaxis

open access: yesBrazilian Journal of Otorhinolaryngology, 2009
openaire   +2 more sources

Haemostatic changes and bleeding with anti‐IL‐6 directed therapy in autoimmune diseases

open access: yesBritish Journal of Pharmacology, Volume 183, Issue 15, Page 4111-4125, August 2026.
Abstract Anti‐IL‐6 directed therapy, especially tocilizumab (TCZ), is widely used for the treatment of autoimmune diseases such as rheumatoid arthritis, giant cell arteritis and systemic juvenile idiopathic arthritis. Next to being a master regulator of inflammation, IL‐6 also is an important regulator of haemostasis. Although generally well tolerated,
Charlotte D. C. C. van der Heijden   +3 more
wiley   +1 more source

Emergency Epistaxis [PDF]

open access: yesProceedings of the Royal Society of Medicine, 1947
openaire   +3 more sources

Home - About - Disclaimer - Privacy